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SUMMARY 
Introduction: Cyclical fluctuations in host immunity have been proposed as a driver of 
respiratory infection seasonality, however few studies have attempted to directly assess 
whether or not seasonal immune modulation occurs in humans.  
Materials and Methods: We reviewed studies assessing immune status at different times of 
the year, restricting our review to studies assessing any of the following three biomarkers: 
antibody responses following vaccination, delayed-type hypersensitivity responses following 
skin testing, and clinical responses following experimental infection.  
Results: After systematic review and critical appraisal of the literature, six separate studies 
were available for final discussion. These results indicate that human immunity does vary by 
season. In the tropical setting of West Africa, both cell mediated and humoral immune 
responses appear to be reduced in children during the rainy season. In the tropical setting of 
Bangladesh, cell mediated immune responses also appear to be reduced in children during the 
rainy season. In the temperate setting of Russia, resistance to influenza infection appears to 
be reduced in young adults during winter.  
Conclusions: Seasonal variation in immunity appears to occur in humans, and it is plausible 
that this variation may contribute to the seasonality of respiratory infections. Further research 
to assess the extent of seasonal immune modulation is required. We outline a number of 
recommendations to minimise bias in future studies. 
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INTRODUCTION 
The seasonal patterns of infectious diseases have been observed for millennia. Seasonality is 
observed in almost all infectious diseases, from respiratory infections such as influenza and 
respiratory syncytial virus,
1, 2
 to diarrheal diseases such as cholera,
3
 and vector borne diseases 
such as malaria.
4
 Despite numerous epidemiological studies investigating infectious disease 
seasonality, the underlying drivers of this seasonality remain unclear for many infections, and 
for respiratory infections in particular. Proposed environmental drivers of respiratory 
infection seasonality include seasonal variations in host contact rates, and seasonal variations 
in the environmental survival of pathogens.
5
 Another proposed driver is seasonal variation in 
host immunity.  Seasonal variations in host resistance to infection have been documented in a 
number of non-human vertebrates,
6
 and there are a number of biologically plausible 
mechanisms that could result in similar seasonal immune modulation in humans. Seasonal 
variation in sunshine levels may play a role: it has been proposed that seasonal variations in 
vitamin D levels could drive respiratory infection incidence,
7
 and seasonal variations in 
photoperiod have also been proposed as a driver of seasonal immune modulation.
8
 Exposure 
to environmental immunotoxins may also vary by season: for example aflatoxin levels are 
often increased in grain and groundnuts stored in non-harvest seasons.
9
 Seasonal variations in 
nutrition also occur in many settings, and the link between malnutrition and reduced host 
resistance to infection is well established in children.
10
  Infectious diseases and host immunity 
are linked in a cyclic manner: while depressed immunity increases the risk of clinical 
infection in those exposed to pathogens, infection itself can debilitate the host, resulting in 
reduced immune defences. Thus some infectious diseases, driven by external seasonal forces 
such as climate, may seasonally debilitate human hosts and in turn predispose to secondary 
infection, resulting in seasonality in this secondary infection. A particularly well documented 
example is that of diarrheal illness in children predisposing them to subsequent pneumonia.
11, 
12
 Whether reduced host immunity is caused directly by environmental factors such as 
reduced sunshine, immunotoxin exposure or malnutrition, or is secondary to other infectious 
diseases, studies to directly assess whether seasonal immune modulation actually occurs in 
humans are a clear starting point to assess all of these hypotheses.  
A number of studies have assessed immune status in humans during different seasons of the 
year. The methods used in these studies differ, and can be classified in two ways: studies can 
be either in vivo or ex vivo studies, and can be either challenge studies (where the immune 
response to an antigen challenge is assessed) or basal studies (where the background levels of 
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immune markers are assessed). In this paper we have restricted our review to studies using 
the following in vivo biomarkers of immune function, which all assess responses to an 
immune challenge: antibody responses to vaccination, delayed type hypersensitivity (DTH) 
responses to skin test antigens, and clinical responses following experimental infection. 
These immune biomarkers are considered to have the best combination of clinical relevance, 
biological sensitivity and practicality.
13, 14
 We have critically reviewed these studies to assess 
whether seasonal immune modulation occurs in human populations. We also discuss whether 
the observed variations in immunity can be plausibly linked to respiratory infection 
seasonality in the study settings. We conclude by recommending a systematic strategy for 
future studies. 
 
MATERIALS AND METHODS 
We searched Medline (search date 18 April 2014) for studies measuring the above 
biomarkers during different seasons. A keyword search was performed using the following 
terms: 
 AB (“immune response*” OR “vaccine response*” OR immunogen* OR "antibody 
response*" OR "delayed type hypersensitivity" OR anergy) AND AB (summer OR winter 
OR spring OR autumn OR "wet season" OR "rainy season" OR "dry season")  
A MESH term search was performed using the following terms: 
((MH "Immunity, Cellular") OR (MH "Immunity, Humoral") OR (MH "Adaptive 
Immunity")) AND (MH "Seasons") 
Search results were restricted to those published in English. We performed citation searches 
of the retrieved articles, and also searched articles citing the retrieved articles using Google 
Scholar. 
 
RESULTS 
Studies examining vaccine antibody responses 
Vaccination elicits antibody production via humoral immunity. For most vaccines, antigen 
presenting cells are activated by vaccine antigens, and then present these antigens to 1) B-
lymphocytes, which then differentiate into antibody producing plasma cells, and 2) T-
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lymphocytes, which facilitate this process (unconjugated polysaccharide vaccines elicit a T-
lymphocyte independent response, where the polysaccharide antigen directly binds to B-
lymphoctes, stimulating their differentiation into antibody producing plasma cells). Thus 
measuring antibody levels following vaccination provides an in vivo measure of an 
integrated, clinically relevant immune response. We found 17 studies examining antibody 
responses according to the season of vaccination. These studies are summarised in Table 1, 
and discussed below.     
 
Rabies vaccine 
Responses to rabies vaccine are a potentially useful biomarker for seasonal analysis because 
rabies antigen does not circulate widely in the environment. A study in 472 Gambian children 
aged between 6 and 9 years found a statistically significant seasonal variation in antibody 
levels following first rabies vaccination, with the strongest antibody responses to rabies 
vaccine if given in May (late dry season).
15
 A study in 257 adults in Pakistan found that 
antibody levels following rabies vaccination (two doses given seven days apart) showed a 
statistically significant monthly variation, with highest responses in August, during the peak 
of summer.
16
 However because the study only included the months from April to September, 
it cannot fully address the question of seasonality.  
 
Hepatitis B virus (HBV) vaccine 
A study in 522 young adults in the Netherlands found little variation in antibody levels 
according to the season of first HBV vaccination (given at 0, 1 and 6 months).
17
 A study in 
138 infants in the Gambia found the highest responses to HBV vaccine (given at 0, 8 and 16 
weeks of age) in infants vaccinated in October and November, however this was not 
statistically significant.
16
 A study in 1874 older children and adults in Austria found 
significantly higher antibody levels following a course of HBV vaccine (given at 0, 1 and 6 to 
12 months) if the third vaccination was performed in winter compared to summer.
18
 
Interpretation of this latter finding is difficult due to the multiple doses of vaccine given 
across different seasons, as well as the variable period between first and third vaccination. In 
addition, antibody responses were measured between 4 weeks and 5 years after finishing the 
HBV vaccine course. 
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Rubella and measles vaccines 
A study in 203 children in Israel found that children receiving a single dose of measles, 
mumps and rubella (MMR) vaccine in the summer had significantly lower rubella antibody 
levels than children vaccinated in the winter.
19
 Children received MMR at age 12 months 
(±10 days), and antibody levels were measured when the children were 4 to 5 years old. Due 
to high vaccine coverage rates, rubella incidence has been very low in Israel since the late 
1990s, suggesting that environmental exposure to rubella antigens is unlikely to have been 
driving the seasonal variation.
20
 A study in 718 children in the Netherlands found no 
differences in antibody levels against measles or rubella according to season of receiving 
MMR vaccination.
17
 These children received MMR at age 14 months, and antibody levels 
were measured at 2 to 7 years of age.   
 
Pneumococcal vaccines 
Antibody levels following a single dose of pneumococcal polysaccharide vaccine in 472 
children aged 6 to 9 years in the Gambia showed complex variation according to the month of 
vaccination, with different seasonal patterns for different serotypes
15, 16
 As part of a Gambian 
vaccine trial, antibody responses following three doses of pneumococcal conjugate vaccine 
(given at 6, 10 and 14 weeks of age) were assessed according to the season of vaccination in 
212 children. Children who received all three doses of vaccine in the rainy season had higher 
antibody levels than those who received doses across both the dry and rainy seasons.
21
 
Pneumococcal antigens circulate cyclically in the environment,
22
 and exposure to 
pneumococcal antigens is known to interfere with the immunogenicity of pneumococcal 
vaccines.
23, 24
 Thus examining the immunogenicity of pneumococcal vaccines according to 
the season of vaccination is particularly vulnerable to confounding from environmental 
antigens, which may explain the inconsistent results from these studies. 
 
Diphtheria and tetanus vaccines 
A study in 138 infants in the Gambia found little variation in antibody responses to diphtheria 
or tetanus according to the month of vaccination.
16
 Infants were vaccinated with combined 
diphtheria, tetanus and pertussis vaccine at 8, 12 and 16 weeks of age, and antibody levels 
were measured at 16 weeks of age. 
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Typhoid vaccine  
A study in 257 adults in Pakistan showed little variation in antibody response according to 
month of vaccination with typhoid vaccine (As noted above however, this study only 
included the months from April to September).
16
 
 
Live influenza vaccines 
Two studies in the former USSR found the highest antibody responses to live intranasal 
influenza vaccines occurred in individuals vaccinated in the winter. In the first study 584 
males aged 16 to 18 years were vaccinated either in June or January. Seroconversion (defined 
as a fourfold or greater increase in antibody levels compared to before vaccination) was  
assessed 20 to 25 days after vaccination, and occurred in 38% of those vaccinated in June and 
51% of those vaccinated in January.
25
 The second study included 588 subjects aged 16 to 18 
years. Those vaccinated in the summer had a lower seroconversion rate (defined as above) 21 
days after vaccination  compared to those vaccinated in winter (16% in summer, compared to 
23% in winter).
26
 
 
Oral polio vaccine (OPV) 
A study in 121 infants in Israel found higher seroconversion rates in infants vaccinated with 
OPV in winter compared to summer.
27
 A study in 50 infants in India also found higher 
seroconversion rates in those infants vaccinated in the winter months.
28
 In the Gambia, a 
study in 679 infants found those infants receiving more OPV vaccinations in the rainy season 
had a lower seroconversion rate.
29
 In contrast to these three studies, a study in 730 infants in 
Brazil did not find any significant variation in OPV immunogenicity according to the season 
of vaccination.
29
 A major driver of the observed seasonal variations in OPV antibody 
responses appears to be the seasonal variation in the prevalence of non-polio enteroviruses: 
infants vaccinated when non-polio enterovirus circulation was at its peak had poorer antibody 
responses to OPV.
27-30
 This strong environmental determinant of OPV immunogenicity 
reduces the usefulness of OPV for assessing seasonal immune modulation.   
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Studies examining DTH responses 
DTH testing involves the intradermal injection of one or more antigens. If the antigen has 
been encountered previously by the individual, this will elicit a cell mediated immune 
response: antigen presenting cells are activated by the intradermal antigens, and then present 
these antigens to memory T-cells, which in turn release cytokines resulting in an infiltration 
of various inflammatory cells. Thus DTH testing provides an in vivo measure of an 
integrated, clinically relevant immune response. The width of the skin induration due to the 
inflammatory response is measured 48 hours after injection of the antigen. Induration less 
than a specific cut off (usually 2mm) is indicative of anergy to that antigen. We found 5 
studies examining DTH responses according to the season of testing. These studies are 
summarised in Table 2, and discussed below.   
Several studies have examined DTH responses to the seven skin test antigens included in the 
multitest kit (proteus, trichophyton, candida, tetanus, diphtheria, streptococcus, and 
tuberculin). In the Gambia, 472 children aged between 6 and 9 years underwent DTH skin 
testing with these seven antigens, with a single administration of the multitest at different 
times of the year in different children. Consistent with the results from the rabies vaccination 
study in this same population, the average number of positive responses to the seven antigens 
was highest in April/May (late dry season).
15
 A study in southern Bangladesh followed a 
cohort of 705 children aged between zero and five years over the course of a year, 
administering the seven multitest antigens at three month intervals. A potential weakness of 
this study was the use of repeated DTH testing in the same children, because repeated DTH 
testing may lead to boosting of the later responses. This may not have biased the results 
substantially however, as a larger proportion of children were anergic to all seven antigens 
upon testing during the rainy season (August, the second DTH test) compared to during the 
hot dry season (May, the first DTH test) despite any boosting that may have resulted from the 
first DTH test: Anergy to all seven antigens occurred in 20.6% of children tested in the rainy 
season compared to 11.8% tested in the hot, dry season (RR 1.74 [95%CI 1.07 to 2.90]) 
31
. In 
a study in northwest Kenya, 57 children aged between 6 months and 10 years were tested 
with five of the seven multitest antigens (the tetanus and diphtheria antigens were removed). 
The children were tested first during the rainy season, and again during the dry season, and 
showed little seasonal variation in DTH responses to the five antigens: 58% of children 
showed anergy to all five antigens during the rainy season, compared to 53% in the dry 
season.
32
 It is possible that boosting due to the repeat testing in this study may have obscured 
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any difference between seasons. A study in Guinea-Bissau administered the seven multitest 
antigens to 884 children at seven to nine months of age. Children were tested once between 
October 1996 and September 1997. The study only reported results for 3 antigens, finding 
that during the rainy season, anergy to tuberculin on DTH skin testing was more common 
(OR 1.76 [95%CI 1.33 to 2.33]) as was anergy to diptheria and tetanus antigens (OR 1.31 
[95%CI 0.99 to 1.72]).
33
 In another study from Guinea-Bissau, anergy to all seven multitest 
antigens upon DTH testing in children aged 3 to 13 years was more common if the children 
were tested in the rainy season compared to the dry season (OR 4.8 [95%CI 2.2 to 10.3]) 
however the study only examined 5 months of the year, and only one of these months (May) 
was during the dry season.
34
 
 
Experimental infection: clinical outcomes following the administration of live vaccines 
Experimental infection provides the most clinically relevant assessment of immune defences 
against infection. Innate, cellular, and humoral immune responses will all be elicited to 
varying degrees to reduce the intensity of infection. Measured outcomes may be 
symptomatology of infection, or microbiological outcomes such as ongoing pathogen 
isolation. We found two studies examining clinical responses according to the season of 
experimental infection. These studies are summarised in Table 3, and discussed below.   
As discussed above, two studies in the former USSR examined human challenge with live 
influenza vaccine in non-immune volunteers. The first of these reported a higher risk of fever 
in 360 individuals vaccinated during the winter compared to 197 vaccinated in summer.
25
 
Although influenza and other viruses causing febrile illness are more common in the winter 
in the study setting, it appears the increased risk of fever in those individuals vaccinated in 
the winter was a direct result of the influenza vaccination, as the placebo group did not show 
any signs of fever during the winter vaccine challenge. The other study from the former 
USSR reported similar results, with a significantly higher risk of fever following influenza 
vaccination in the winter compared to in the summer, and a significantly higher amount of 
nasal secretion of vaccine virus two and three days following vaccination in winter compared 
to summer.
26
 Taken together these studies suggest that in winter, vaccinated individuals are 
more likely to become infected with the vaccine viruses, with subsequent viral replication and 
fever.  
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DISCUSSION 
Sources of bias in the retrieved studies 
During our critical appraisal of the studies retrieved by our literature search, we identified a 
number of sources of bias specific to studies comparing immune status at different time of the 
year. These sources of bias are discussed below, and in Tables 1 to 3 we also indicate which 
studies are at risk of these biases.  
 
Circulating antigens 
If a test antigen circulates seasonally in the environment (as is the case for many antigens 
including pneumococcal, enteroviral and tuberculin antigens) any seasonal variation observed 
in immune responses following challenge with these antigens may be due to variations in the 
level of circulating antigen rather than variations in immune competence.
23, 35
 For this reason, 
when assessing seasonal immune modulation using vaccines it is advisable to use responses 
to vaccine antigens that are not circulating in the environment. Because DTH testing 
examines the immune response to previously encountered antigens, environmental antigens 
are required as the test antigens. Thus to minimise confounding when using DTH testing it is 
advisable to use a combination of antigens with different seasonal patterns of circulation, 
such as when assessing the proportion of children with anergy to all seven of the antigens in 
the DTH multitest. Anergy to all seven multitest antigens is a more reliable measure of 
reduced immune competence than a negative result to a single antigen.
15
 
 
Age and sex 
Immune responses vary with age, and age specific responses to immune challenge (whether 
the challenge is vaccine, DTH test, or infection) are well documented in many studies.
15, 16, 36
 
For DTH testing there is an additional complication: as previous exposure to the test antigen 
is required for a positive DTH reaction, this means negative DTH reactions are more 
common in younger children, who have had less chance for previous exposure.
31
 These 
factors clearly implicate age as a potential confounder in any study assessing seasonal 
immune modulation. A second factor that needs to be considered is the potential for 
confounding by birth cohort effects. If all children are the same age at antigen challenge 
(particularly if they are infants) then disentangling the effect of the season of birth from the 
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effect of the season of antigen challenge will be difficult. For example if all children are six 
months old at antigen challenge, and those children challenged in March have reduced 
responses, is would be difficult to assess whether this was due to an environmental insult in 
March, or sometime during their gestation (January to September the previous year). 
Examples of birth cohort effects would include seasonal variations in maternal antibody 
levels,
29, 37, 38
 which can affect responses to antigen challenge in infants,
39, 40
 as well as 
maternal exposures during gestation, which could potentially result in altered responses to a 
wide variety of antigens in children according to season of birth.
41
 In order to properly 
control for both age and birth cohort effects in multivariate analysis, the antigen challenge 
should be administered to children of different ages (to avoid birth cohort effects) and the 
analysis of seasonal variation in immune response should be adjusted for any age difference 
between the comparison groups. Responses to immune challenge also often vary according to 
sex, and this should also be controlled for in multivariate analysis. 
 
Follow-up time following challenge 
The strength of an immune response also varies with time following challenge. For DTH 
testing, skin tests are routinely read 48 hours after challenge. For vaccinations the follow-up 
time is less consistent. Follow-up times must be equal following challenges in different 
seasons to avoid confounding, and it would be prudent to test antibody responses within one 
to two months following vaccination (some of the reviewed studies measured antibody levels 
several years following vaccination, allowing the potential for other environmental factors to 
influence the immune response in the interim). Follow-up times should also be equal for 
studies using experimental infection, as symptoms will vary with time following infection, 
according to the incubation period. 
 
Repeated immune challenges 
Repeat immune challenges with the same antigen may lead to boosting of later responses. For 
DTH testing the available evidence suggests such boosting is probably maximal if DTH tests 
are repeated within two months, however some boosting may occur if DTH tests are repeated 
up to a year later.
42-45
 The boosting effect of repeated vaccination is well known. The 
simplest way to avoid bias due to boosting is to assess immune responses to antigen 
challenge in different subjects at different times of the year.  
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Antigen storage 
The immunogenicity of antigens depends on adequate storage, in particular the maintenance 
of the cold chain during transport and storage. In many settings maintaining the cold chain 
may be more difficult at different times of the year. High temperatures in summer, and 
difficulties in transport during the rainy season, are two seasonal factors that may be 
detrimental to proper vaccine storage. Most of the reviewed papers have documented the 
efforts taken to maintain the cold chain during the studies. No papers reported any observed 
problems with cold chain maintenance. 
 
Possible drivers of seasonal immune modulation 
Table 4 lists the studies least likely to be affected by the sources of bias discussed above, and 
include studies using rabies vaccine (1 study), multitest DTH responses (3 studies), and 
experimental infection (2 studies). Possible drivers of the observed seasonal variation in 
immunity in these six studies are discussed below. 
In the Gambia, immune responses in children following both rabies vaccine and DTH 
multitest were strongest late in the dry season (April/May). Similarly, in nearby Guinea-
Bissau, anergy to the DTH multitest in children was less common in May than during the 
rainy season. In this part of West Africa the rainy season is often a time of poor nutrition 
known as the hungry season,
46, 47
 and this malnutrition is exacerbated by an increased 
incidence of diarrheal illness during the rainy season.
4, 48
 A number of studies have 
demonstrated a direct link between poor nutritional status, reduced cell mediated immune 
responses, and an increased risk of infection in children.
31, 49-51
 In contrast, vaccine responses 
appear less affected by malnutrition.
52
 Malaria infection is also at its peak during the rainy 
season, driven by increased mosquito numbers. Malaria infection appears to affect host 
immunity: malaria parasitaemia reduces the antibody response to some vaccines and malaria 
parasitaemia also appears to affect DTH responses to some antigens.
53-55
 In the Gambian 
study, children with malaria parasitaemia had reduced responses to the rabies vaccine, but 
parasitaemia did not affect DTH testing. Whatever the cause of the apparent reduction in both 
cell mediated and humoral immunity during the rainy season in this setting, it appears 
plausible that this seasonal reduction in immunity may drive further infections. Respiratory 
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infections in children are generally at their peak late in the rainy season in the Gambia.
56
 The 
timing of this peak is consistent with respiratory infection seasonality being at least partly 
driven by the observed seasonal reduction in cellular and/or humoral immunity. 
In Bangladesh, anergy to all seven DTH multitest antigens was more common upon testing in 
the rainy season compared to the hot dry season. As with the West African examples, in 
Bangladesh the rainy season is often a time of poor nutrition, with reduced household food 
security and decreased maternal and child growth.
57, 58
 Malaria is not endemic in the district 
the DTH study was performed in. It is plausible that the observed seasonal reduction in 
cellular immunity may play a role in driving the seasonality of respiratory infections in this 
setting. Respiratory infections in children generally occur at two times of the year in 
Bangladesh: during the winter, and late in the rainy season.
59, 60
 The timing of the second 
peak is consistent with respiratory infection incidence being at least partly driven by the 
observed seasonal reduction in cell mediated immunity. 
In young adults in the temperate climate of the former USSR, fever and viral secretion were 
less frequent following nasal inoculation with live influenza vaccine in the summer. Possible 
underlying causes for seasonal immune modulation in temperate winters are reduced nutrition 
and reduced vitamin D levels. It is possible that micronutrient intake may fluctuate with 
season due to the availability of seasonal produce: this appears to be the case in Russia, 
where micronutrient deficiencies are generally more severe in winter and spring.
61
 Vitamin D 
levels are consistently lower during the winter and spring months in temperate settings, and 
vitamin D deficiency appears to increase the risk of respiratory infection in children.
62-64
 The 
most specific effect of vitamin D deficiency on immunity is a reduction in the antimicrobial 
peptide cathelicidin, part of the innate immune system, and expressed in leukocytes and 
bronchial epithelial cells.
65, 66
 In this temperate setting, respiratory infections are most 
common in late winter/early spring.
67, 68
 While improved viral survival due to the low winter 
temperatures in temperate settings is one plausible driver of this seasonal variation in 
respiratory infections, reduced immune competence during the winter may also play a role in 
driving the observed seasonality of respiratory infections. 
  
CONCLUSIONS 
The studies reviewed here suggest seasonal immune modulation occurs in humans, and that 
seasonal immune modulation in humans is a plausible driver of the observed seasonal 
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patterns of respiratory infections in the reviewed settings. Other driving factors undoubtedly 
are also influencing transmission and seasonality of infectious diseases: variations in climate 
are likely to affect pathogen survival in the environment, while host mixing behaviour is also 
likely to vary throughout the year. Further research is required to assess the relative 
importance of these different driving mechanisms. The dominant factors driving infectious 
disease seasonality are likely to vary according to the infection, and according to the setting. 
It remains to be seen whether or not the observed seasonal patterns of immune modulation 
may be amenable to intervention. For example, immune modulation resulting from seasonal 
variation in day length may prove difficult to address, while immune modulation due to 
malnutrition or vitamin D deficiency is more amenable to intervention. Improved 
understanding of the mechanisms underlying the seasonality of immune modulation may 
enable more effective use of interventions. The fact that seasonal immune modulation is 
apparent at the population level suggests that interventions for population groups at risk of 
reduced immune competence may have “herd” level benefits as well as individual level 
benefits.  
Our review has also demonstrated the lack of studies examining seasonal changes in clinical 
measures of human immunity. We have focused our review on studies examining three 
clinical measures of immune status (vaccine immunogenicity, DTH responses, and infectious 
challenge) because of the high relevance of these measures to clinical outcomes. This strategy 
has reduced the number of studies available for our review, and our critical appraisal of the 
retrieved articles has further reduced the number of articles available for interpretation. More 
research is required to better understand the dynamics of host immune modulation. To this 
end we have made several recommendations for reducing bias in future studies using the 
clinical measures reviewed in this article (Box 1).  
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Box 1: Recommendations for reducing bias when assessing seasonal immune modulation 
 To assess consistency from year to year, ideally studies should continue for several 
years. 
 To better assess causality, regular measurements of immune status (ideally monthly) 
are preferable. 
 For vaccines, use antigens that do not circulate in the environment.  
 For DTH testing, assess anergy to a number of test antigens administered at the same 
time. 
 To avoid confounding, maintain similar age and sex distributions of children in the 
comparison groups (or control for any differences in analysis). 
 Administer the antigen challenge to children over a range of ages in order to control 
for birth cohort effects. 
 For vaccines, testing the antibody response after a single dose will give clearer results.  
 Avoid repeated challenges in the same subjects as this can cause boosting of 
responses.  
 The delay between the immune challenge and measurement of the immune response 
should be the same in the comparison groups (and it would be prudent to test antibody 
levels within two months of vaccination). 
 Ensure cold chain maintenance is the same during different seasons. 
 
 
Table 1: Summary of studies assessing seasonal variation in vaccine responses 
Immune challenge Setting Study 
size 
Age at challenge Season with 
strongest 
immune 
response 
Antigen 
circulating in 
environment? 
Age and sex 
controlled for or 
distributed 
equally? 
Challenge - 
test interval 
Equal challenge-
test interval in 
all subjects?  
Rabies vaccine15 Gambia 472 6 to 9 years Dry season No Yes 14 days Yes 
Rabies vaccine16 Pakistan 257 25 to 35 years Summer No Yes 7 days Yes 
HBV vaccine17 Netherlands 522 17 to 20 years None  Minimal ND Various No 
HBV vaccine16 Gambia 138 0 to 16 weeks* Unclear Yes Yes 36 weeks Yes 
HBV vaccine18 Austria 1874 6 to 80 years Unclear Minimal ND 4 weeks to 5 
years 
No 
Rubella vaccine19 Israel 203 12 months* Winter Minimal ND 3 to 4 years No 
Rubella vaccine17 Netherlands 718 14 months* None Minimal ND 1 to 6 years No 
PPV15, 16 Gambia 472 6 to 9 years Unclear Yes Yes 4 weeks Yes 
PCV21 Gambia 212 6 to 18 weeks* Rainy season Yes ND 4 weeks Yes 
Diphtheria/tetanus 
vaccine16 
Gambia 138 8 and 12 
weeks* 
None  Yes Yes 4 weeks Yes 
Typhoid vaccine16 Pakistan 257 25 to 35 years None Yes Yes 14 days Yes 
Influenza vaccine25 Russia 584 16 to 18 years Winter Yes Yes 20 to 25 days No 
Influenza vaccine26 Russia 588 16 to 18 years Winter Yes ND 21 days Yes 
OPV27 Israel 121 2 to 6 months* Winter Yes ND 2 months Yes 
OPV28 India 50 3 to 9 months Winter Yes ND 2 weeks Yes 
OPV29 Gambia 679 1 to 5 months* Dry season Yes ND ≥ 4 weeks No 
OPV29 Brazil 730 0 to 3 months* None Yes ND 4 weeks Yes 
HBV: hepatitis B virus / PPV: pneumococcal polysaccharide vaccine / PCV: pneumococcal conjugate vaccine / OPV: oral polio vaccine / ND: not documented 
*Potential for birth cohort effect 
 
 
 
Table 2: Summary of studies assessing seasonal variation in DTH responses 
Immune challenge Setting Study 
size 
Age at 
challenge 
Season with 
strongest 
immune 
response 
Antigen 
circulating in 
environment? 
Age and sex 
controlled for or 
distributed 
equally? 
Potential for 
birth cohort 
effect? 
Equal challenge-
test interval in 
all subjects?  
Multitest DTH15 Gambia 472 6 to 9 years Dry season Yesb Yes No Yes 
Multitest DTH31  Bangladesh 705 0 to 5 years Dry season Yesb No No Yes 
Multitest DTH32  Kenya 57 0 to 10 years None Yesb No No Yes 
Multitest DTH33 Guinea-
Bissau 
884 7 to 9 months Dry season Yesb Yes Yes Yes 
Multitest DTH34 Guinea-
Bissau 
391 3 to 13 years Dry season Yesb Yes No Yes 
bHowever multiple antigens were tested 
 
 
Table 3: Summary of studies assessing seasonal variation in clinical responses to experimental infection 
Immune challenge Setting Study 
size 
Age at 
challenge 
Season with 
least clinical 
infections 
Antigen 
circulating in 
environment? 
Age and sex 
controlled for or 
distributed 
equally? 
Potential for 
birth cohort 
effect? 
Equal challenge-
test interval in 
all subjects?  
Influenza infection25 Russia 557 16 to 18 years Summer Yesc Yes No Yes 
Influenza infection26 Russia 471 16 to 18 years Summer Yes ND No Yes 
cHowever study was placebo controlled  
 Table 4: Summary of studies included in final discussion 
Setting Challenge Study 
size 
Age at 
challenge 
Comparison Results 
Gambia15 Rabies 
vaccine 
472 6 to 9 
years 
Months from 
April to 
February 
The strongest antibody 
response was in children 
vaccinated in May (end of dry 
season) 
Gambia15 Multitest 
DTH 
472 6 to 9 
years 
Months from 
April to 
February 
The number of positive 
responses (out of seven 
antigens) was highest in April 
and May (end of dry season) 
Bangladesh31 Multitest 
DTH  
705 0 to 5 
years 
May v August Anergy to all seven antigens 
was more common in August 
(mid rainy season) than May 
(end of dry season) 
Guinea-
Bissau34 
Multitest 
DTH 
391 3 to 13 
years 
Months from 
May to 
September 
Anergy to all seven antigens 
was least common in May (end 
of dry season) 
Russia25 Influenza 
infection 
557 16 to 18 
years 
June v January Higher risk of fever in those 
infected during January (winter) 
compared to those infected in 
June (summer) 
Russia26 Influenza 
infection 
471 16 to 18 
years 
June v 
February  
Higher risk of fever, and 
increased nasal secretion of 
virus, in those infected during 
February (winter) compared to 
those infected in June (summer)  
 
